The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds
90% when diagnosed after age 65. Most cases arise without any detectable early symptoms …

NF-E2–related factor 2 (Nrf2) transcription factor regulates a range of cytoprotective
transcriptional responses, preventing further cellular injury by removing biochemical damage and …

Despite currently available therapies, most patients diagnosed with acute myeloid leukemia
(AML) die of their disease. Tumor-host interactions are critical for the survival and …

Improvements in the understanding of the metabolic cross-talk between cancer and its
microenvironment are expected to lead to novel therapeutic approaches. Acute myeloid leukemia …

Splenomegaly is a feature of a broad range of diseases, and presents to clinicians in many
fields. This review examines the aetiology of splenomegaly in the developed world, and …

Multiple myeloma relies on both oxidative phosphorylation and glycolysis following acquisition
of mitochondria from its bone marrow microenvironment. See related commentary by …

Background The impact of hemoglobin levels and anemia on stroke mortality remains
controversial. We aimed to systematically assess this association and quantify the evidence. …

Acute infection is known to induce rapid expansion of hematopoietic stem cells (HSCs), but
the mechanisms supporting this expansion remain incomplete. Using mouse models, we …

Acute Myeloid Leukaemia (AML) is a genetically, biologically and clinically heterogeneous
set of diseases, which are characterised by an increased growth of abnormal myeloid …

Objectives Stroke‐associated pneumonia ( SAP ) is common and associated with adverse
outcomes. Data on its impact beyond 1 year are scarce. Materials and methods This …